文献速递腹部CT

肝脏影像报告和数据系统用于CT诊断肝细胞癌:主要征象与辅助征象的表现

LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本回顾性研究纳入59例(104个病灶,其中72个肝细胞癌)临床怀疑肝细胞癌并于2013至2016年行增强CT的患者,由两名放射科医师独立评估主要及辅助影像征象并分配LI-RADS类别。结果显示,LR-5类别对肝细胞癌诊断的特异度接近完美,辅助征象仅使少数观察的最终类别发生改变。

要点

  • LR-5类别对肝细胞癌诊断的特异度为97.3%,敏感度为53.7%。
  • 主要征象中动脉期高强化敏感度86.1%、特异度39.3%,廓清敏感度81.6%、特异度67.9%。
  • 辅助征象仅使104个观察中的4个最终类别发生改变。

核心结论

  • 在CT上,LR-5类别对肝细胞癌诊断具有接近完美的特异度,辅助征象仅使少数观察的最终类别发生改变。

研究设计与样本

  • 回顾性研究,纳入59例患者(104个观察,包括72个肝细胞癌),临床怀疑肝细胞癌,于2013至2016年行增强CT;以病理或影像作为复合参考标准;两名放射科医师独立评估。

诊断标准与关键数值

  • 主要征象对肝细胞癌:动脉期高强化敏感度86.1%、特异度39.3%;廓清敏感度81.6%、特异度67.9%;包膜敏感度20.7%、特异度89.9%;阈值增长敏感度26.1%、特异度85.0%。
  • 辅助征象对肝细胞癌:超声可见离散结节敏感度42.6%、特异度79.2%;亚阈值增长敏感度50.8%、特异度66.9%;肿块内脂肪多于邻近肝实质敏感度15.1%、特异度96.4%。
  • LI-RADS类别对肝细胞癌诊断:LR-3敏感度5.3%、特异度49.1%;LR-4敏感度29.0%、特异度84.4%;LR-5敏感度53.7%、特异度97.3%;LR-TIV(静脉内癌栓)敏感度10.7%、特异度96.4%。
  • 辅助征象使104个观察中的4个最终类别发生改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the diagnostic performance of Liver Imaging Reporting and Data System (LI-RADS) v2017 major features, the impact of ancillary features, and categories on contrast-enhanced computed tomography (CECT) for the diagnosis of hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: This retrospective study included 59 patients (104 observations including 72 HCCs) with clinical suspicion of HCC undergoing CECT between 2013 and 2016. Two radiologists independently assessed major and ancillary imaging features for each liver observation and assigned a LI-RADS category based on major features only and in combination with ancillary features. The composite reference standard included pathology or imaging. Per-lesion estimates of diagnostic performance of major features, ancillary features, and LI-RADS categories were assessed by generalized estimating equation models.

RESULTS: Major features (arterial phase hyperenhancement, washout, capsule, and threshold growth) respectively had a sensitivity of 86.1%, 81.6%, 20.7%, and 26.1% and specificity of 39.3%, 67.9%, 89.9%, and 85.0% for HCC. Ancillary features (ultrasound visibility as discrete nodule, subthreshold growth, and fat in mass more than adjacent liver) respectively had a sensitivity of 42.6%, 50.8%, and 15.1% and a specificity of 79.2%, 66.9%, and 96.4% for HCC. Ancillary features modified the final category in 4 of 104 observations. For HCC diagnosis, categories LR-3, LR-4, LR-5, and LR-TIV (tumor in vein) had a sensitivity of 5.3%, 29.0%, 53.7%, and 10.7%; and a specificity of 49.1%, 84.4%, 97.3%, and 96.4%, respectively.

CONCLUSION: On CT, LR-5 category has near-perfect specificity for the diagnosis of HCC and ancillary features modifies the final category in few observations.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Alhasan A, Cerny M, Olivié D, et al. LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Abdom Radiol (NY). 2019. PMID: 30167771. doi:10.1007/s00261-018-1762-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。